Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Sep 5;295(6598):567-9.
doi: 10.1136/bmj.295.6598.567.

Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection

Affiliations

Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection

C Pedersen et al. Br Med J (Clin Res Ed). .

Abstract

A total of 276 sequential serum samples from 34 men with antibodies to the human immunodeficiency virus (HIV) followed up for two to seven years were analysed for HIV antigen and antibodies to the viral core and envelope proteins. Results were correlated with clinical outcome and CD4 T lymphocyte count. Both antigenaemia and the disappearance of antibodies to the core protein were associated with development of the acquired immune deficiency syndrome (AIDS) or AIDS related complex and depletion of CD4 cells. Thus AIDS or AIDS related complex developed in eight out of 16 patients with antigenaemia compared with one out of 18 patients without antigenaemia. Low counts of CD4 cells (less than 0.5 X 10(9)/l) were found in 14 of the 16 patients with antigenaemia and five of the 18 without antigenaemia. Nine patients seroconverted to HIV during the study; two of these developed antigenaemia 14 and 16 months after the estimated time of seroconversion. These results show that the late stages of HIV infection are characterised by increased production of antigen and a decrease in antibodies directed against the core protein. Antigenaemia indicates a poor prognosis; and as the antigen test is simple to do and interpret, it may therefore be useful for selecting patients for antiviral treatment.

PubMed Disclaimer

References

    1. Br Med J (Clin Res Ed). 1982 Jul 3;285(6334):17-9 - PubMed
    1. Science. 1984 Jul 20;225(4659):321-3 - PubMed
    1. Br Med J (Clin Res Ed). 1985 Oct 12;291(6501):997-8 - PubMed
    1. Br Med J (Clin Res Ed). 1986 Jan 25;292(6515):228-30 - PubMed
    1. Lancet. 1986 Jul 26;2(8500):177-80 - PubMed

Publication types

MeSH terms